BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 18677232)

  • 1. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear lipocalin and lysozyme concentrations in postmenopausal women.
    Srinivasan S; Joyce E; Boone A; Simpson T; Jones L; Senchyna M
    Ophthalmic Physiol Opt; 2010 May; 30(3):257-66. PubMed ID: 20444132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 expression in Sjogren's syndrome, KCS, and control subjects.
    Caffery B; Heynen ML; Joyce E; Jones L; Ritter R; Senchyna M
    Mol Vis; 2010 Aug; 16():1720-7. PubMed ID: 20806091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC16 expression in Sjogren's syndrome, KCS, and control subjects.
    Caffery B; Joyce E; Heynen ML; Jones L; Ritter R; Gamache DA; Senchyna M
    Mol Vis; 2008; 14():2547-55. PubMed ID: 19122828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
    Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
    Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
    Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
    Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
    Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
    Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome and tear function parameters.
    van Bijsterveld OP; Mackor AJ
    Clin Exp Rheumatol; 1989; 7(2):151-4. PubMed ID: 2736827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women.
    Careba I; Chiva A; Totir M; Ungureanu E; Gradinaru S
    J Med Life; 2015; 8 Spec Issue(Spec Issue):94-8. PubMed ID: 26366224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system.
    Szalai E; Berta A; Szekanecz Z; Szûcs G; Módis L
    Cornea; 2012 Aug; 31(8):867-71. PubMed ID: 22580437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
    Chung JK; Kim MK; Wee WR
    Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between dry eye and rheumatoid arthritis activity.
    Fujita M; Igarashi T; Kurai T; Sakane M; Yoshino S; Takahashi H
    Am J Ophthalmol; 2005 Nov; 140(5):808-13. PubMed ID: 16289424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome.
    Wakamatsu TH; Sato EA; Matsumoto Y; Ibrahim OM; Dogru M; Kaido M; Ishida R; Tsubota K
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):144-50. PubMed ID: 19696170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
    Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
    Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients.
    Qiu X; Gong L; Lu Y; Jin H; Robitaille M
    Acta Ophthalmol; 2012 Aug; 90(5):e359-66. PubMed ID: 22568661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic power of the tests for tear gland related keratoconjunctivitis sicca.
    Klaassen-Broekema N; Mackor AJ; van Bijsterveld OP
    Neth J Med; 1992 Apr; 40(3-4):113-6. PubMed ID: 1603200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.